Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus

Lupus

Volumn 20, Issue 13, 2011, Pages 1421-1425

  Minhas, U ^a   Das, P ^b   Bhatnagar, A ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

immune complex; oxidative stress; pristane induced lupus; reactive intermediates; SLE like disease; systemic lupus erythematosus

Indexed keywords

NITRIC OXIDE; PRISTANE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; LUPUS LIKE SYNDROME; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PRISTANE INDUCED LUPUS;

ANIMALS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TERPENES;

EID: 81555227087     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311418791     Document Type: Article

References (24)

1. Hoffman IEA, Peene I, Meheus L, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis. 2004 ; 63: 1155-1158 (Pubitemid 39120371)
2. Shaheen VM, Satoh M, Richards HB, et al. Immunopathogenesis of environmentally induced lupus in mice. Environ Health Perspect. 1999 ; 107: 723-727 (Pubitemid 29527776)
3. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994 ; 180: 2341-2346 (Pubitemid 24351616)
4. Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res. 2009 ; 43: 117-127
5. Zhang Q, Ye DQ, Chen GP, Zheng Y. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin Exp Dermatol. 2010 ; 35: 287-294
6. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis. 1993 ; 52: 659-666 (Pubitemid 23280435)
7. Perricone C, De Carolis C, Perricone R. Glutathione: A key player in autoimmunity. Autoimmun Rev. 2009 ; 8: 697-701
8. Sukkar SG, Rossi E. Oxidative stress and nutritional prevention in autoimmune rheumatic diseases. Autoimmun Rev. 2004 ; 3: 199-206 (Pubitemid 38521095)
9. Nacionales DC, Kelly KM, Lee PY, et al. Type 1 interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethylel- pentadecane (pristane). Am J Pathol. 2006 ; 168: 1227-1240
10. Sarkar M, Varshney R, Chopra M, Sekhri T, Adhikari JS, Dwarakanath BS. Flow-cytometric analysis of ROS in PBMC of patients with thyroid dysfunction. Cytometry B Clin Cytom. 2006 ; 70: 20-23
11. Yamamoto K, Akbar SM, Masumoto T, Onji M. Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC). Clin Exp Immunol. 1998 ; 114: 94-101 (Pubitemid 28442819)
12. Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother. 2004 ; 58: 325-337 (Pubitemid 38759732)
13. Shoenfeld Y, Agmon-Levin N. 'ASIA' e Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011 ; 36: 4e8
14. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009 ; 18: 1217-1225
15. Kurien BT, Scofield RH. Lipid peroxidation in SLE. Indian J Exp Biol. 2006 ; 44: 349-356
16. Tetik S, Ahmad S, Alturfan AA, et al. Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. Indian J Biochem Biophys. 2010 ; 47: 353-358
17. Van Dyke K, Jabbour N, Hoeldtke R, Van Dyke C, Van Dyke M. Oxidative/nitrosative stresses trigger type I diabetes: preventable in streptozotocin rats and detectable in human disease. Ann N Y Acad Sci. 2010 ; 203: 138-145
18. Rho YH, Chung CP, Oeser A, et al. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010 ; 62: 1473-1480
19. Kumagai S, Jikimoto T, Saegusa J. Pathological roles of oxidative stress in autoimmune diseases. Rinsho Byori. 2003 ; 51: 126-32
20. Khan F, Khan F, Ali R. Immunogenicity of DNA modified by singlet oxygen: implications in systemic lupus erythematosus and cancer. Biotechnol Appl Biochem. 2007 ; 46: 97-103
21. Nagy G, Koncz A, Fernandez D, Perl A. Nitric oxide, mitochondrial hyperpolarization and T cell activation. Free Radic Biol Med. 2007 ; 42: 1625-1631 (Pubitemid 46629013)
22. Oates JC, Gilkeson GS. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin. Immunol. 2006 ; 121: 243-250 (Pubitemid 44738713)
23. Oates JC. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity. 2010 ; 43: 56-63
24. Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?. Autoimmun Rev. 2008 ; 7: 544-549